Data gathered: December 21
AI Stock Analysis - Tilray (TLRY)
Analysis generated October 7, 2024. Powered by Chat GPT.
Tilray (NASDAQ: TLRY) is a prominent global player in the cannabis industry, engaged in the research, cultivation, processing, and distribution of cannabis and cannabis-derived products. Tilray's extensive portfolio includes medical cannabis, hemp products, and recreational cannabis products across multiple markets worldwide. Being a pioneer, Tilray has managed to establish a significant presence not only in North America but also in global markets such as Europe and Latin America.
Stock Alerts - Tilray (TLRY)
 |
Tilray | December 21 Reddit mentions are up by 326% in the last 24h. |
|
Tilray | December 20 Price is up by 5.2% in the last 24h. |
|
Tilray | December 19 Reddit mentions are up by 284% in the last 24h. |
|
Tilray | December 18 Price is down by -5.2% in the last 24h. |
Alternative Data for Tilray
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 66 | Sign up | Sign up | Sign up |
| Sentiment | 81 | Sign up | Sign up | Sign up |
| Webpage traffic | 34,000 | Sign up | Sign up | Sign up |
| Employee Rating | 62 | Sign up | Sign up | Sign up |
| Google Trends | 38 | Sign up | Sign up | Sign up |
| Patents | 8 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | 28 | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 74 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 151,042 | Sign up | Sign up | Sign up |
| Twitter Followers | 34,360 | Sign up | Sign up | Sign up |
| Twitter Mentions | 97 | Sign up | Sign up | Sign up |
| News Mentions | 1 | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| ESG | 25 | Sign up | Sign up | Sign up |
| Business Outlook | 37 | Sign up | Sign up | Sign up |
| Linkedin Employees | 988 | Sign up | Sign up | Sign up |
About Tilray
Tilray is a Canadian pharmaceutical and cannabis company, incorporated in the United States with primary operations headquartered in Toronto, Ontario. Tilray also has operations in Australia, New Zealand, Germany, Portugal, and Latin America.
| Price | $1.26 |
| Target Price | Sign up |
| Volume | 35,340,000 |
| Market Cap | $1.05B |
| Year Range | $1.16 - $2.47 |
| Dividend Yield | 0% |
| Analyst Rating | 29% buy |
| Earnings Date | January 9 '25 |
| Industry | Medical Cannabis |
In the news
 |
Tilray's CEO Makes a Bold Prediction: Is the Stock a Buy?December 21 - Biztoc.com |
 |
Tilray Brands, Inc. Receives Stockholder Approval for Increase in Authorized SharesDecember 20 - ETF Daily News |
|
FY2025 EPS Estimates for Tilray Raised by Atb Cap MarketsDecember 19 - ETF Daily News |
 |
Tilray Brands, Inc. (TLRY) Flat As Market Sinks: What You Should KnowDecember 19 - Yahoo |
 |
Better Marijuana Stock: Aurora Cannabis or Tilray Brands?December 19 - Biztoc.com |
Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025December 19 - Financial Post |
|
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 213M | 237M | 60M | -39M | -15M | -0.040 |
| Q1 '24 | 179M | 227M | 49M | -93M | -61M | -0.120 |
| Q4 '23 | 189M | 231M | 47M | -49M | -20M | -0.070 |
| Q3 '23 | 171M | 212M | 44M | -72M | -12M | -0.100 |
| Q2 '23 | 98M | 24M | 67M | -139M | -68M | -0.150 |
Insider Transactions View All
| Merton Carl A filed to buy 26,000 shares at $1.4. November 18 '24 |
| FALTISCHEK DENISE M filed to buy 293,269 shares at $2.1. January 18 '24 |
| Gendel Mitchell filed to buy 195,796 shares at $2. January 16 '24 |
| Gendel Mitchell filed to buy 188,596 shares at $1.9. January 12 '24 |
| Merton Carl A filed to buy 20,000 shares at $1.9. January 12 '24 |
Similar companies
| Company | Price | AI Score | |
|---|---|---|---|
 |
Canopy GrowthCGC |
$2.83 0% | 36 |
 |
Aurora CannabisACB |
$4.27 0% | 34 |
 |
Sundial GrowersSNDL |
$1.8 0% | 33 |
 |
OrganigramOGI |
$1.56 0% | 33 |
 |
Cronos GroupCRON |
$1.95 0% | 49 |
Read more about Tilray (TLRY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, patents, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of Tilray?
The Market Cap of Tilray is $1.05B.
When does Tilray report earnings?
Tilray will report its next earnings on January 9 '25.
What is the current stock price of Tilray?
Currently, the price of one share of Tilray stock is $1.26.
How can I analyze the TLRY stock price chart for investment decisions?
The TLRY stock price chart above provides a comprehensive visual representation of Tilray's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Tilray shares. Our platform offers an up-to-date TLRY stock price chart, along with technical data analysis and alternative data insights.
Does TLRY offer dividends to its shareholders?
As of our latest update, Tilray (TLRY) does not offer dividends to its shareholders. Investors interested in Tilray should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of Tilray?
Some of the similar stocks of Tilray are Canopy Growth, Aurora Cannabis, Sundial Growers, Organigram, and Cronos Group.
.